ANRS Emerging Infectious Diseases (MIE), Santé Publique France and the Haute Autorité de santé are organizing a scientific day on Long Covid to be held on October 14, 2024 at PariSanté Campus, Paris. The day will provide an opportunity to take stock of scientific advances, address outstanding issues and define future research priorities for ANRS MIE and its partners.
14 October 2024
The challenge that Long Covid represents for the health of those affected, for public health and for healthcare professionals, has prompted ANRS Emerging Infectious Diseases (MIE), Santé Publique France and the Haute Autorité de santé to organize this scientific day to mobilize researchers, associations and institutions, and strengthen their collaboration.
Post-Covid Syndrome or Long Covid is a medical reality, confirmed by epidemiological studies. The burden of this disease can be intense, with a major impact on daily personal, social and professional life. Research has identified certain determinants of Long Covid, and various pathophysiological hypotheses are currently being explored.
However, these advances still fail to explain the multiple clinical pictures. Therapeutic proposals to date remain disappointing. Recent publications testify to scientific advances, but also underline the urgent need for further research. Some of the research and management questions raised by Long Covid are similar to those posed by other post-infectious syndromes, and could therefore benefit from a common approach. Working on Long Covid can help us to tackle existing, poorly understood problems, but can also prepare us to deal with the emergence of new infectious agents.
Faced with this challenge for the health of those affected, for public health and for healthcare professionals, ANRS Emerging Infectious Diseases, Santé Publique France and the Haute Autorité de santé are organizing this scientific day to mobilize researchers, associations and institutions, and to strengthen their collaboration.
9:00 Doors open – Coffee welcome
9:30 am Opening
9h50 Session 1: Epidemiology – population studies
10:50 Session 2.1: Pathophysiology (part 1)
12:10 pm Session 3: Children and Long Covid
12h40 Lunch
14:00 Session 2.2: Pathophysiology (part 2)
15h10 Break
3:30 pm Session 4: Clinical trials
16:00 Round table: Understanding persistent symptoms and prioritizing future research
16:45 Closing session
5:00 pm Cocktail
Olivier Robineau
(Centre Hospitalier de Tourcoing, University of Lille)
Marc Bardou
(Centre Hospitalier Universitaire Dijon Bourgogne, Université de Bourgogne Franche-Comté)
Inés Ben Ghezala
(Centre Hospitalier Universitaire Dijon Bourgogne, Université de Bourgogne Franche-Comté)
Lisa Chakrabarti
(Institut Pasteur)
Joël Coste
(Santé publique France)
Jérôme Estaquier
(Inserm, University of Paris)
Pierre Gabach
(Haute Autorité de Santé)
France Lert
(ANRS Emerging Infectious Diseases (MIE))
Xavier Lescure
(Assistance Publique – Hôpitaux de Paris (AP-HP), Paris)
Aurélie Morand
(Assistance Publique – Hôpitaux de Marseille (AP-HM), Marseille)
Pauline Oustric
(Association Après J20)
Eric Rosenthal
(ANRS Emerging Infectious Diseases (MIE))
Pascal Sève
(Hospices Civils de Lyon)
Séverine Delhaye-Grelois
(Association Après J20)
Tom Lachaise
(Association Après J20)